{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T05:31:57Z","timestamp":1794547917721,"version":"4.9.1"},"reference-count":17,"publisher":"The Pediatric Pharmacy Association","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:sec>\n          <jats:title>OBJECTIVE<\/jats:title>\n          <jats:p>The intent of this project was to objectively describe the frequency of pharmacist prescribing in acute care pediatrics and neonatology and to determine the medications most often prescribed by pharmacists practicing in a jurisdiction that permits pharmacists' prescribing.<\/jats:p>\n        <\/jats:sec>\n        <jats:sec>\n          <jats:title>METHODS<\/jats:title>\n          <jats:p>This was a subgroup analysis of a retrospective observational study using prescribing data from an electronic medical record system used in 5 acute care hospitals (1 pediatric, 4 primarily adult but with pediatric and neonatal units) within Calgary, Alberta, Canada.<\/jats:p>\n        <\/jats:sec>\n        <jats:sec>\n          <jats:title>RESULTS<\/jats:title>\n          <jats:p>Considering orders for pediatric or neonatal patients only, there was a mean (SD) of 126 (226) prescriptions per pharmacist per year, with a wide range (1\u20131101 per year). Considering only the 9 clinical pharmacist full-time equivalents (FTEs) assigned to pediatrics and\/or neonatology (i.e., not including dispensary pharmacist FTE), this represents 572 prescriptions per clinical pharmacist FTE per year (726 in pediatrics and 380 in neonatology). The most common medication classes on pediatric units included anti-infective agents, central nervous system agents, and gastrointestinal agents. In NICUs, blood formation, coagulation and thrombosis agents (mainly iron), electrolytes, caloric and water balance agents (primarily sodium supplements), and vitamins were also commonly prescribed by pharmacists.<\/jats:p>\n        <\/jats:sec>\n        <jats:sec>\n          <jats:title>CONCLUSIONS<\/jats:title>\n          <jats:p>As the scope of pharmacy practice expands to include prescribing, health team leadership can use these data to support incorporation of this role into practice. Prescribing pharmacists can ensure appropriate use of many medications used in acutely ill infants and children, potentially improving efficiency and quality of care.<\/jats:p>\n        <\/jats:sec>","DOI":"10.5863\/1551-6776-25.7.600","type":"journal-article","created":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T23:36:34Z","timestamp":1601422594000},"page":"600-605","source":"Crossref","is-referenced-by-count":4,"title":["Pharmacist Prescribing in Pediatric and Neonatal Acute Care: An Observational Study"],"prefix":"10.5863","volume":"25","author":[{"given":"Amanda","family":"Barton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deonne","family":"Dersch-Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydney","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Mysak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalyce","family":"Zuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3883","reference":[{"key":"i1551-6776-25-7-600-b1","article-title":"Standards of Practice for Pharmacists and Pharmacy Technicians","year":"2019","unstructured":"Alberta College of Pharmacy.\n          Standards of Practice for Pharmacists and Pharmacy Technicians. 2019. https:\/\/abpharmacy.ca\/sites\/default\/files\/StandardsofPractice.pdf. Accessed September 11, 2019."},{"issue":"2","key":"i1551-6776-25-7-600-b2","series-title":"Pharm World Sci","first-page":"45","article-title":"Independent prescribing by pharmacists: a study of the awareness, views and attitudes of Scottish community pharmacists","volume":"28","year":"2006","unstructured":"George\n              J\n            , PflegerD, McCaigD, \n          et al. Independent prescribing by pharmacists: a study of the awareness, views and attitudes of Scottish community pharmacists. Pharm World Sci. 2006;28(2):45\u201353."},{"issue":"3","key":"i1551-6776-25-7-600-b3","series-title":"Health Policy (New York)","first-page":"277","article-title":"Nurse and pharmacist supplementary prescribing in the UK\u2014a thematic review of the literature","volume":"85","year":"2008","unstructured":"Cooper\n              RJ\n            , AndersonC, AveryT, \n          et al. Nurse and pharmacist supplementary prescribing in the UK\u2014a thematic review of the literature. Health Policy (New York). 2008;85(3):277\u2013292."},{"issue":"9","key":"i1551-6776-25-7-600-b4","series-title":"BMJ Open","first-page":"e003154","article-title":"Pharmacist intervention for glycaemic control in the community (the RxING study)","volume":"3","year":"2013","unstructured":"Al Hamarneh\n              YN\n            , CharroisT, LewanczukR, TsuyukiRT.\n          Pharmacist intervention for glycaemic control in the community (the RxING study). BMJ Open. 2013;3(9):e003154. doi: 10.1136\/bmjopen-2013-003154"},{"issue":"8","key":"i1551-6776-25-7-600-b5","series-title":"CMAJ","first-page":"1","article-title":"Case management for blood pressure and lipid level control after minor stroke: PREVENTION randomized controlled trial","volume":"186","year":"2014","unstructured":"McAlister\n              FA\n            , MajumdarSR, PadwalRS, \n          et al. Case management for blood pressure and lipid level control after minor stroke: PREVENTION randomized controlled trial. CMAJ. 2014;186(8):1\u20138."},{"issue":"2","key":"i1551-6776-25-7-600-b6","series-title":"Circulation","first-page":"93","article-title":"Randomized trial of the effect of pharmacist prescribing on improving blood pressure in the community","volume":"132","year":"2015","unstructured":"Tsuyuki\n              RT\n            , HouleSKD, CharroisTL, \n          et al. Randomized trial of the effect of pharmacist prescribing on improving blood pressure in the community. Circulation. 2015;132(2):93\u2013100."},{"issue":"24","key":"i1551-6776-25-7-600-b7","series-title":"J Am Coll Cardiol","first-page":"2846","article-title":"The effectiveness of pharmacist interventions on cardiovascular risk: the multicenter randomized controlled RxEACH trial","volume":"67","year":"2016","unstructured":"Tsuyuki\n              RT\n            , Al HamarnehYN, JonesCA, HemmelgarnBR.\n          The effectiveness of pharmacist interventions on cardiovascular risk: the multicenter randomized controlled RxEACH trial. J Am Coll Cardiol. 2016;67(24):2846\u20132854."},{"issue":"24","key":"i1551-6776-25-7-600-b8","series-title":"Am J Health Syst Pharm","first-page":"2166","article-title":"Independent prescribing by hospital pharmacists: patterns and practices in a Canadian province","volume":"72","year":"2015","unstructured":"Heck\n              T\n            , GuntherM, BreseeL, \n          et al. Independent prescribing by hospital pharmacists: patterns and practices in a Canadian province. Am J Health Syst Pharm. 2015;72(24):2166\u20132174."},{"key":"i1551-6776-25-7-600-b9","series-title":"Int J Pharm Pract","first-page":"56","article-title":"An evaluation of pharmacist prescribing in a hospital setting","volume":"21","year":"2013","unstructured":"Baqir\n              W\n            , CrehanO, MurrayR, \n          et al. An evaluation of pharmacist prescribing in a hospital setting. Int J Pharm Pract. 2013;21:56\u201357."},{"key":"i1551-6776-25-7-600-b10","series-title":"GPhC Registrant Survey 2013","year":"2014","unstructured":"Phelps\n              A\n            , AgurM, NassL, BlakeM.\n          GPhC Registrant Survey 2013. 2014. https:\/\/www.pharmacyregulation.org\/sites\/default\/files\/gphc_registrant_survey_2013_main_report_by_natcen.pdf. Accessed October 30, 2019."},{"issue":"6","key":"i1551-6776-25-7-600-b11","series-title":"Arch Dis Child","first-page":"e1","article-title":"Pharmacist prescribing in neonatal intensive care units in the UK (abstract from the 18th Neonatal and Paediatric Pharmacists Group Annual Conference 9\u201311 November 2012)","volume":"98","year":"2013","unstructured":"Mulholland\n              P.\n            \n          \n          Pharmacist prescribing in neonatal intensive care units in the UK (abstract from the 18th Neonatal and Paediatric Pharmacists Group Annual Conference 9\u201311 November 2012). Arch Dis Child. 2013;98(6):e1."},{"issue":"11","key":"i1551-6776-25-7-600-b12","series-title":"Drug Saf","first-page":"1031","article-title":"Interventions of hospital pharmacists in improving drug therapy in children: a systematic literature review","volume":"29","year":"2006","unstructured":"Sanghera\n              N\n            , ChanPY, KhakiZF, \n          et al. Interventions of hospital pharmacists in improving drug therapy in children: a systematic literature review. Drug Saf. 2006;29(11):1031\u20131047."},{"issue":"1","key":"i1551-6776-25-7-600-b13","series-title":"PLOS One","first-page":"e30856","article-title":"Clinical pharmacists on medical care of pediatric inpatients: a single-center randomized controlled trial","volume":"7","year":"2012","unstructured":"Zhang\n              C\n            , ZhangL, HuangL, \n          et al. Clinical pharmacists on medical care of pediatric inpatients: a single-center randomized controlled trial. PLOS One. 2012;7(1):e30856. doi:10.1371\/journal.pone.0030856"},{"issue":"3","key":"i1551-6776-25-7-600-b14","series-title":"Res Soc Adm Pharm","first-page":"269","article-title":"Interdisciplinary medication decision making by pharmacists in pediatric hospital settings: an ethnographic study","volume":"14","year":"2018","unstructured":"Rosenfeld\n              E\n            , KinneyS, WeinerC, \n          et al. Interdisciplinary medication decision making by pharmacists in pediatric hospital settings: an ethnographic study. Res Soc Adm Pharm. 2018;14(3):269\u2013278."},{"issue":"3","key":"i1551-6776-25-7-600-b15","series-title":"Res Soc Adm Pharm","first-page":"342","article-title":"Calgary zone usage of additional prescribing authorization by pharmacists in an inpatient setting: review of the prescribing landscape and environment (CAPABLE)","volume":"16","year":"2020","unstructured":"Saunders\n              S\n            , Dersch-MillsD, MysakT, \n          et al. Calgary zone usage of additional prescribing authorization by pharmacists in an inpatient setting: review of the prescribing landscape and environment (CAPABLE). Res Soc Adm Pharm. 2020;16(3):342\u2013348."},{"key":"i1551-6776-25-7-600-b16","series-title":"AHFS Pharmacologic-Therapeutic Classification","year":"2019","unstructured":"American Society of Health-Systems Pharmacy.\n          AHFS Pharmacologic-Therapeutic Classification. 2019. https:\/\/www.ahfsdruginformation.com\/ahfs-pharmacologic-therapeutic-classification\/. Accessed April 2, 2019."},{"issue":"22","key":"i1551-6776-25-7-600-b17","series-title":"Am J Health Syst Pharm","first-page":"1983","article-title":"Survey of Alberta hospital pharmacists' perspectives on additional prescribing authorization","volume":"69","year":"2012","unstructured":"Hutchison\n              M\n            , LindbladA, GuirguisL, \n          et al. Survey of Alberta hospital pharmacists' perspectives on additional prescribing authorization. Am J Health Syst Pharm. 2012;69(22):1983\u20131992."}],"container-title":["The Journal of Pediatric Pharmacology and Therapeutics"],"original-title":[],"link":[{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/25\/7\/article-p600.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/meridian.allenpress.com\/jppt\/article-pdf\/25\/7\/600\/2605883\/1551-6776-25_7_600.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/25\/7\/article-p600.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/25\/7\/article-p600.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:40:28Z","timestamp":1747356028000},"score":1,"resource":{"primary":{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/25\/7\/article-p600.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":17,"journal-issue":{"issue":"7"},"URL":"https:\/\/doi.org\/10.5863\/1551-6776-25.7.600","relation":{},"ISSN":["1551-6776"],"issn-type":[{"value":"1551-6776","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]}}}